Linfoma no hodgkin (LNH) difuso en pacientes con la infección por el virus de inmunodeficiencia humana (VIH) tratamiento con: ciclofosfamida-doxorrubicina-vincristina-prednison (CHOP): reporte final

Hernández, Dimas; Pérez, José; Somoza, Rosa.
Arch. Hosp. Vargas ; 40(1/2): 57-60, ene.-jun. 1998. ilus, tab
Artículo en Español | LILACS | ID: lil-225737

Documentos relacionados

  1. [Epigenetic abnormalities in non-Hodgkin lymphomas].
  2. A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.
  3. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
  4. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
  5. Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
  6. Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
  7. [Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
  8. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
  9. Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study.
  10. MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech.